Top CBD Stock To Explode Higher!

RoboStreet – June 6, 2019

Embracing the Oncoming CBD Profit Wave

The advent of the secular cannabis trend, now in its second year in which investors can buy publicly traded pot companies; there are several avenues by which the industry is rapidly growing to address various aspects of the marketplace. Strategic partnerships are being formed between the biggest pot producers with multinational consumer brand giants and high-profile billionaire investors that have brought rising credibility to the nascent sector and capital flows into cannabis companies continues to be robust.

Taking center stage within the various investment themes is the growing popularity of cannabidiol or CBD. Unlike THC, which is the psychoactive compound in marijuana that creates the experience of getting “high”, CBD is a chemical compound that has a benign effect on the mind, but is proactive in treating a wide variety of bodily ailments. CBD is found in both marijuana and hemp and is now found in a vast number of products ranging from coffee, ice cream, teas, candy to body lotions.

The primary target market for CBD is pain management, inflammation and treating anxiety. While scientific studies are somewhat fleeting to support the efficacy of CBD in these areas, there are many advocates cheerleading the positive effects the natural properties of CBD have versus the proven effectiveness of synthetic compounds. CBD also shouldn’t be confused with medical marijuana, which has demonstrated to reduce certain levels of pain.

 “I’m investing my own money in each and every stock as my AI platform identifies.”

And remember we’re not talking about day-trading here.  I’m looking for 50-100% gains inside of the next 3 months, so my weekly updates are timely enough for you to act.

Click Here – To See Where I Put My RoboInvestor Money

The recent legalization of hemp being signed into the 2018 Farm Bill gave the CBD industry of big dose of momentum. Historically, hemp has been used to manufacture rugs, rope, paper and textiles. Farming hemp legally opens the way for farmers across the country to grow and supply the fast expanding CBD market with each state being responsible for the oversight of how domestically grown hemp is distributed.

Just this past week, over 100 speakers within the industry ranging from doctors, health professionals, researchers, producers and critics attended a hearing sponsored by the Food and Drug Administration to pour over the wide variety of views on CBD and the state of the industry where regulatory structure is varied and devoid of industry standards. The takeaway from the frayed and some contentious opinions being cast from all sides is that the FDA is about to get highly involved in the regulation of CBD.

And the stakes are high for those first-to-market companies. “According to the Brightfield Group, a cannabis analytics firm, the CBD market is on track to generate $591 million in sales in 2018. However, by 2022, hemp-CBD sales are projected to reach… drumroll… $22 billion. This represents a compound annual growth rate of 147% over the next four years.” If they are even half-right, it’s still a bonanza that smacks of a 49er gold rush and this is why pot stocks carry such high valuations.

Source: Getty Images

Looking at which companies stand to cash in early on the CBD craze, one not need to look any further than Aurora Cannabis (ACB),the largest producer of marijuana in North America and already one of the biggest CBD oil companies in the world.  Aurora’s primary target is the medical treatment market and is set to be the leading CBD oil supplier in the U.S. given its current capacity to grow pot production to 570,000 kilograms per year.

Europe has already framed standards within their Good Manufacturing Practices (GMP) for CBD product quality control whereby Aurora Cannabis is in full compliance with current regulations. This early adoption by Europe to Aurora’s CBD cannabis distribution subsidiary Pedanios should lay the groundwork for rapid introduction by the FDA to standardize CBD rules and regulations in the U.S. with Aurora being a potential honey pot for investors.

In the first quarter of 2019, Aurora saw international revenue soar 40% quarter-over-quarter and is forecasting to earn a profit in the current second quarter on adjusted EBITDA from sales of more than 25,000 kg of weed. This would represent year-over-year production growth of more than 20x and cements Aurora’s wide competitive lead in international markets- already including 24 countries with huge potential in Germany.

For investors seeking to harvest a small fortune in the pot rush, the landscape is fraught with trap doors, snake oil companies, shady promoters and serial stock issuers that dilute shareholder equity on a daily basis. This is where having some artificial intelligence becomes hyper-valuable. Most of the leading pot stocks got off to a big start and have come back to earth as the real numbers start to define the industry and profit potential. Current data is very erratic, so having tools to guide investors is essential to knowing which stocks to buy and when to buy them.

Just this past week, those subscribers to myRoboInvestor stock advisory service booked strong profits in blue chip cardiology equipment provider Medtronic PLC (MDT)while also taking full advantage of the recent gold rally with the sale of the VanEck Gold Miners ET (GDX) for a 12.12% gain. Not bad in a market where the S&P has declined for five of the six past weeks.

Prior to these gains, we banked profits in Waste Management (WM),power utility WEC Energy (WEC), Abbott Labs (ABT)and Alphabet (GOOGL) during the month of May when most stocks were under severe selling pressure. A $10,000 investment in each stock would have produced $2,988 in realized profits over the course of a month. My AI platform offers investors a track-record proven system of producing consistent profits where 93.75% of the time- the trades dedicated to RoboInvestorsgenerate gains with an average return per trade of 4.85%.

Of the 60 trades closed within the RoboInvestorservice during the past 15 months since the service was launched, 56 have been profitable. As headlines and tweets keep volatility and uncertainty elevated, having an agnostic, apolitical and always-thinking AI machine working 24/7 to ferret out the highest probability trades is what RoboInvestoris fully dedicated to and represents my life’s work and expertise.

Don’t let the market get the best of your emotions and timing. Put the power of AI to work today and eliminate much of the risk that my number-crunching algorithms provide, as well as identifying tomorrow’s winning trades. RoboInvestor– a pure AI solution.

 “I’m investing my own money in each and every stock as my AI platform identifies.”

And remember we’re not talking about day-trading here.  I’m looking for 50-100% gains inside of the next 3 months, so my weekly updates are timely enough for you to act.

Click Here – To See Where I Put My RoboInvestor Money

*Please note: RoboStreet is part of your free subscription service. It is not included in any paid Tradespoon subscription service. Vlad Karpel only trades his own personal money in paid subscription services.  If you are a paid subscriber, please review your Premium Member Picks, ActiveTrader, MonthlyTrader, or RoboInvestor recommendations. If you are interested in receiving Vlad’s personal picks, please click here.